BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 1273483)

  • 1. [Antibody-dependent cytotoxicity of blood lymphocytes during rheumatoid polyarthritis].
    Sany J; Clot J; Freitas M; Charmasson E; Serre H
    Rev Rhum Mal Osteoartic; 1976 May; 43(5):333-8. PubMed ID: 1273483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lymphocytic subpopulations implicated in the rheumatoid rosette phenomenon].
    Sany J; Clot J; Sip HM; Charmasson E; Serre H
    Rev Rhum Mal Osteoartic; 1975 May; 42(5):309-16. PubMed ID: 806958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Fc-gamma-receptor cells and rheumatoid arthritis].
    Sany J; Clot J; Andary M; Paradis B; Serre H
    Rev Rhum Mal Osteoartic; 1978 May; 45(5):305-10. PubMed ID: 675118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study of T and B lymphocytes in blood and synovial fluid during rheumatoid arthritis].
    Sany J; Clot J; Rosenberg F; Serre H
    Rev Rhum Mal Osteoartic; 1977 May; 44(5):317-22. PubMed ID: 329397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [EA rosettes in patients with progressive chronic polyarthritis].
    Scherak O; Sitko C; Eibl M; Kolarz G
    Z Rheumatol; 1976; 35(3-4):103-7. PubMed ID: 1083608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T and B cell patterns in irreversibly rejected human renal allografts. Correlation of morphology with surface markers and cytotoxic capacity of the isolated lymphoid infiltrates.
    Busch GJ; Schamberg JF; Moretz RC; Strom TB; Tilney NL; Carpenter CB
    Lab Invest; 1976 Sep; 35(3):272-80. PubMed ID: 785094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro studies on lymphocytotoxicity to synovial cells and Chang cells in rheumatoid arthritis patients and healthy controls.
    Warnatz H; Thommes M
    Z Rheumatol; 1979; 38(3-4):129-37. PubMed ID: 312567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological characteristics of lymphocytes in synovial fluid and peripheral blood in patients with rheumatoid arthritis.
    Michałkiewicz J
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):801-5. PubMed ID: 312088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of lymphocytes bearing Fcgamma receptors to PHA-induced cytotoxicity.
    Cordier G; Samarut C; Revillard JP
    Immunology; 1978 Jul; 35(1):49-56. PubMed ID: 308041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Separation and properties of EA-rosette-forming lymphocytes in humans.
    van Oers MH; Zeijlemaker WP; Schellekens PT
    Eur J Immunol; 1977 Mar; 7(3):143-50. PubMed ID: 324774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of antibody-dependent cell-mediated cytotoxicity in rheumatoid synovial fluid.
    Abrahamsen TG
    Scand J Rheumatol; 1981; 10(1):55-61. PubMed ID: 7221496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inhibition of expontaneous cytotoxicity and antibody dependency by rheumatoid synovial fluid].
    Noguera Hernando E; Kreisler M; Durantez A; Larrea Gayarre A; de Landazuri MO; Cruz Martínez J
    Allergol Immunopathol (Madr); 1978; 6(3):253-62. PubMed ID: 717203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-mediate cytotoxicity in vitro of human lymphocytes against a tissue culture melanoma cell line (igr3).
    Peter HH; Pavie-Fischer J; Fridman WH; Aubert C; Cesarini JP; Roubin R; Kourilsky FM
    J Immunol; 1975 Aug; 115(2):539-48. PubMed ID: 1171141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study between Fc receptor bearing cells and antibody dependent cell cytotoxicity in cancer patients.
    Gutiérrez F; Sánchez-Cantalejo E; Garcia-Olivares E; Garrido F; Osorio C
    Rev Esp Fisiol; 1980 Sep; 36(3):243-7. PubMed ID: 7433748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytochemical studies of rosette-forming cells.
    Mackiewicz S; Brelińska-Peczalska R; Celińska-Szpytko E
    Z Immunitatsforsch Exp Klin Immunol; 1975 May; 148(5):462-6. PubMed ID: 127452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surface markers on lymphocytes of multiple sclerosis patients.
    Nowak J; Wajgt A
    Clin Exp Immunol; 1975 Aug; 21(2):278-83. PubMed ID: 1102165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of mononuclear effector cells in human blood.
    Hersey P; Edwards A; Edwards J
    Clin Exp Immunol; 1976 Jan; 23(1):104-13. PubMed ID: 1083316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural cytotoxic reactivity of human lymphocytes against a myeloid cell line: characterization of effector cells.
    West WH; Cannon GB; Kay HD; Bonnard GD; Herberman RB
    J Immunol; 1977 Jan; 118(1):355-61. PubMed ID: 299761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analyses of lymphocytes from patients with rheumatoid arthritis and systemic lupus erythematosus. Occurrence of interfering cold-reactive antilymphocyte antibodies.
    Winchester RJ; Winfield JB; Siegal F; Wernet P; Bentwich Z; Kunkel HG
    J Clin Invest; 1974 Nov; 54(5):1082-92. PubMed ID: 4138924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic lymphocyte-dependent antibodies (LDA). Specificity of Fc receptors.
    Fournier C; Lesavre P; Bach JF
    Transplantation; 1977 Mar; 23(3):239-47. PubMed ID: 324044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.